Literature DB >> 18348309

Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins.

Yoshitsugi Hokama1, Cara Empey-Campora, Cynthia Hara, Nicole Higa, Nathaniel Siu, Rachael Lau, Tina Kuribayashi, Kenichi Yabusaki.   

Abstract

This study examined 328 CFS sera in a study with 17 CCFP, 8 Gulf War Veterans (GWV), 24 Prostate Cancer (PC), and 52 normal sera in the modified Membrane Immunobead Assay (MIA) procedure for CTX. Three hundred and twenty-eight CFS patients' sera were examined by the modified MIA with purified MAb-CTX and 91.2% gave a titre > or =1:40. 76% of the 17 CCFP sera samples and 100% of the 8 GWV sera samples also had a titre > or =1:40. 92.3% of 52 normal sera showed titres of 1:20 or less, while 4 gave titres of > or =1:40. In addition, 41 sera were examined for Anti-Cardiolipin (aCL) by a commercial ELISA procedure with 87.8% demonstrating IgM, IgM+IgA, or IgM+IgG aCL antibodies. These results showed mostly the IgM aCL antibody alone in the sera samples. In addition, 41 serum samples were examined for aCL, with 37 showing positive for aCL, representing 90.2% positive for the three disease categories examined: CFS, CCFP and GWV. Examination for antiMitochondrial-M2 autoantibody (aM-M2) in 28 patients (CFS (18), CCFP (5), and GWV (5)) was negative for aM-M2. Inhibition analysis with antigens, CTX, CFS "Acute Phase Lipids", commercial Cardiolipin (CL) and 1,2-Dipalmitoyl-sn-Glycero-3-[Phospho-L-Serine] (PS) and antibodies, MAb-CTX and aCL from patients' serum show that the phospholipids in CL and CTX are antigenically indistinguishable with antibodies MAb-CTX and CFS-aCL. Preliminary chemical analyses have shown the lipids to be phospholipids associated with CL of the mitochondria. We designate this "Acute Phase Lipid" comparable to "Acute Phase Proteins" (C-reactive protein (CRP) and Serum Amyloid A (SAA)) in inflammatory conditions. (Copyright ) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348309      PMCID: PMC6649096          DOI: 10.1002/jcla.20217

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

Review 1.  Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.

Authors:  R Cervera; R A Asherson; M L Acevedo; J A Gómez-Puerta; G Espinosa; G De La Red; V Gil; M Ramos-Casals; M García-Carrasco; M Ingelmo; J Font
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

2.  A simple membrane immunobead assay for detecting ciguatoxin and related polyethers from human ciguatera intoxication and natural reef fishes.

Authors:  Y Hokama; W E Takenaka; K L Nishimura; J S Ebesu; R Bourke; P K Sullivan
Journal:  J AOAC Int       Date:  1998 Jul-Aug       Impact factor: 1.913

3.  Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.

Authors:  Azzudin E Gharavi; Silvia S Pierangeli; Ricardo G Espinola; Xiaowei Liu; Margaret Colden-Stanfield; E Nigel Harris
Journal:  Arthritis Rheum       Date:  2002-02

4.  Clinical aspects of ciguatera (fish poisoning) in French Polynesia.

Authors:  R Bagnis
Journal:  Hawaii Med J       Date:  1968 Sep-Oct

Review 5.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

Authors:  M B Pepys; M L Baltz
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

6.  Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis.

Authors:  Christos Liaskos; Eirini Rigopoulou; Kalliopi Zachou; Sarah Georgiadou; Nikolaos Gatselis; Roidoula Papamihali; George N Dalekos
Journal:  J Autoimmun       Date:  2005-05       Impact factor: 7.094

7.  Neurology of ciguatera.

Authors:  J Pearn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

8.  Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I.

Authors:  C González; A Lestón; B García-Berrocal; A Sánchez-Rodriguez; J A Martín-Oterino; I Alberca; M Cordero; R Jorge; J A Navajo; J M González-Buitrago
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

9.  Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus.

Authors:  S Loizou; J K Cazabon; M J Walport; D Tait; A K So
Journal:  Arthritis Rheum       Date:  1997-01

Review 10.  Viral infections and antiphospholipid antibodies.

Authors:  Imad W Uthman; Azzudin E Gharavi
Journal:  Semin Arthritis Rheum       Date:  2002-02       Impact factor: 5.532

View more
  15 in total

1.  Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome.

Authors:  Yoshitsugi Hokama; Cara Empey Campora; Cynthia Hara; Tina Kuribayashi; Diana Le Huynh; Kenichi Yabusaki
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.

Authors:  Olga V Danilenko; Natalia Y Gavrilova; Leonid P Churilov
Journal:  Pathophysiology       Date:  2022-05-25

Review 3.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 4.  Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.

Authors:  Assaf Menachem; Joab Chapman; Yael Deri; Chaim G Pick; Aviva Katzav
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

5.  Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.

Authors:  Kenny L De Meirleir; Svetlana F Khaiboullina; Marc Frémont; Jan Hulstaert; Albert A Rizvanov; András Palotás; Vincent C Lombardi
Journal:  In Vivo       Date:  2013 Mar-Apr       Impact factor: 2.155

6.  Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature.

Authors:  Kristin Filler; Debra Lyon; James Bennett; Nancy McCain; Ronald Elswick; Nada Lukkahatai; Leorey N Saligan
Journal:  BBA Clin       Date:  2014-06-01

Review 7.  A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?

Authors:  Navena Navaneetharaja; Verity Griffiths; Tom Wileman; Simon R Carding
Journal:  J Clin Med       Date:  2016-06-06       Impact factor: 4.241

8.  Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors.

Authors:  Noha Abdel-Wahab; Jean H Tayar; Faisal Fa'ak; Gaurav Sharma; Maria A Lopez-Olivo; Abdelrahman Yousif; Tasneam Shagroni; Sami Al-Hawamdeh; Cristhiam M Rojas-Hernandez; Maria E Suarez-Almazor
Journal:  Blood Adv       Date:  2020-04-28

Review 9.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.

Authors:  Gerwyn Morris; George Anderson; Piotr Galecki; Michael Berk; Michael Maes
Journal:  BMC Med       Date:  2013-03-08       Impact factor: 8.775

Review 10.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.